Triple
T4210365
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Clinical and Translational Science Awards Program |
E93885
|
entity |
| Predicate | predecessor |
P97
|
FINISHED |
| Object |
National Center for Research Resources clinical and translational programs
The National Center for Research Resources clinical and translational programs were NIH initiatives that supported infrastructure and resources to accelerate the translation of laboratory discoveries into clinical applications and improved patient care.
|
E425098
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: National Center for Research Resources clinical and translational programs | Statement: [Clinical and Translational Science Awards Program, predecessor, National Center for Research Resources clinical and translational programs]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: National Center for Research Resources clinical and translational programs Context triple: [Clinical and Translational Science Awards Program, predecessor, National Center for Research Resources clinical and translational programs]
-
A.
Clinical and Translational Science Awards Program
The Clinical and Translational Science Awards Program is a U.S. national consortium that supports academic medical institutions in accelerating the translation of scientific discoveries into improved patient care and public health.
-
B.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
C.
Office of Translational Sciences
The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
-
D.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
E.
NCI-Designated Cancer Centers Program
The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: National Center for Research Resources clinical and translational programs Triple: [Clinical and Translational Science Awards Program, predecessor, National Center for Research Resources clinical and translational programs]
Generated description
The National Center for Research Resources clinical and translational programs were NIH initiatives that supported infrastructure and resources to accelerate the translation of laboratory discoveries into clinical applications and improved patient care.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: National Center for Research Resources clinical and translational programs Target entity description: The National Center for Research Resources clinical and translational programs were NIH initiatives that supported infrastructure and resources to accelerate the translation of laboratory discoveries into clinical applications and improved patient care.
-
A.
Clinical and Translational Science Awards Program
The Clinical and Translational Science Awards Program is a U.S. national consortium that supports academic medical institutions in accelerating the translation of scientific discoveries into improved patient care and public health.
-
B.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
C.
Office of Translational Sciences
The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
-
D.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
E.
NCI-Designated Cancer Centers Program
The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69b3451743608190808f41d17ccf2650 |
completed | March 12, 2026, 10:58 p.m. |
| NER | Named-entity recognition | batch_69b34810de648190b09c5e705cf0a74e |
completed | March 12, 2026, 11:11 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b5a84ffb18819081fcd4b258ccfedf |
completed | March 14, 2026, 6:26 p.m. |
| NEDg | Description generation | batch_69b5a8e024a081909e7ecbe969793281 |
completed | March 14, 2026, 6:28 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69b5acefd1f881908226ff68a741552b |
completed | March 14, 2026, 6:46 p.m. |
Created at: March 12, 2026, 11:03 p.m.